Free Research Report Download:
The Cancer Market Outlook To 2014
Free Pharmaceutical Market Research Reports
Biotechnology
Corporate & Fiscal
Drug Delivery
Health Products
Hospital Markets
Indication Areas
Medical Devices
Prescription Medicines
R&D
Custom Research
Pharmaceutical Events & Conferences
Contact
Terms & Conditions
Privacy
Dermatological Drugs: World Market Prospects 2012-2022
Management Report
Published: January 2012
Pages: 168
Tables: For full details, please email deborahf@cmsinfo.com
From: GBP 1699.00 Buy Now!
Research from: pharmaceuticalmarketresearch
Sector: Prescription Medicines
This study assesses drugs to treat human skin disorders. You discover sales predictions at world market, therapeutic submarket, product and national levels to 2022.
How will 24 leading drugs - Valtrex, Zovirax, Protopic, Enbrel and others - perform from 2012? Our report gives you business research and analysis with many sales forecasts.
Also, you see forecasting of five derma submarkets to 2022, finding potential revenues:
• Dermatitis
• Psoriasis
• Acne
• Infectious skin diseases
• Miscellaneous dermatologics.
What does the future hold? The pharma industry has potential for improved treatments and increased revenues from dermatological agents. The R&D pipeline is strong.
Our report discusses GSK, Galderma, Amgen, Abbott, J&J and other pharmaceutical companies, assessing prospects of the industry and market.
Many commercial opportunities in treating skin disorders remain, including increased revenues. You can investigate the future of that area now.
Visiongain's study provides data, analysis and opinion aiming to benefit your research, calculations, meetings and presentations. You find answers in our work.
Revenue forecasts, market shares, developmental trends and discussions
In our report you find revenue forecasting, growth rates and market shares. Also, you have qualitative analyses (including SWOT) and discussion of R&D activities. You receive 121 tables and charts and a research interview.
Advantages of Dermatological Drugs: World Market Prospects 2012-2022 for your work
In particular, this study gives you the following knowledge on the topic:
• Find potential revenues to 2022 for the world market and submarkets
• Discover revenue forecasts to 2022 for 24 leading products
• See market forecasting to 2022 for the US, Japan, the EU5, China and India
• Assess leading companies, discovering activities and outlooks
• Review R&D, seeing pipeline trends
• Investigate competition and opportunities influencing sales
• Find out what will stimulate and restrain the industry and market
• View opinion from the sector, receiving primary research.
There, you find a distinctive mix of quantitative and qualitative analyses with independent predictions. Without our report, you could miss out on information that your competitors are using.
We investigate commercial applications of dermatology, helping you to stay ahead.
Gain business research and analysis for the treatment of skin disorders
Companies Listed
3SBio
Abbott Laboratories
Actavis
Actelion Pharmaceuticals
Albert Einstein College of Medicine
Allergan
Almirall
Altana
American Academy of Dermatology
Amgen
Anacor Pharmaceuticals
AndroScience Corp
AnGesMG
Anterios
Antigenics
Apotex
Apotheca
Applied Genetics
aRigen Pharmaceuticals
Astellas Pharma
Astion
Asubio Pharma
Aurobindo Pharma
Barr
Basilea
Bayer
Bio3 Research
BioCryst Pharmaceuticals
BioMAS
Biomed Research & Technologies
Biotest
Biovail
Birken
Braintree Laboratories
Bristol-Myers Squibb
British Association of Dermatologists
Can-Fite Biopharma
Celgene Corporation
Centocor Ortho Biotech
Cipher Pharmaceuticals
CollaGenex Pharmaceuticals
Cosmo Pharmaceuticals
Creabilis Therapeutics
Critical Therapeutics
Cytotech Labs
DAVA Pharmaceuticals
DeNova Research
Derma Sciences
Dow Pharmaceutical Sciences
Dr. Reddy's Laboratories
DUSA Pharmaceuticals
Eisai
Eli Lilly
Epiphany
European Medicines Agency (EMEA/EMA)
Foamix
Food and Drug Administration (US FDA)
Forward Pharma
Fougera
G&W Labs
Galderma
Gene Signal International
Genzyme
GlaxoSmithKline (GSK)
Glenmark
Graceway Pharmaceuticals
Gruenenthal
Hanwha Pharmaceutical
Hetero Drugs
Immune Control
Immune Control
Immune Technologies & Medicine GmbH
Impax Laboratories
Incyte Corporation
Inhibitex
iNova Pharmaceuticals
INSERM
Intendis
Isotechnika Pharma
Jannsen Biotech
Janssen-Cilag
Johnson & Johnson (J&J)
Kaken Pharmaceutical
KV Pharmaceuticals
Kythera Biopharmaceuticals
L.A.L. Clinica Pesquisa e Desenvolvimento
Laboratorio Teuto Brasiliero
Laboratorios Goulart
LEO Pharma
Ligand Pharmaceuticals
L'Oréal
Lupin
Maruho Co.
Matrix Laboratories
Mayne
Meda AB
Medicines and Healthcare Products Regulatory Agency (MHRA, UK)
Medicis
Medimetriks
Medivir AB
Merck & Co.
Merz Pharmaceuticals
Mitos Pharmaceuticals
Mitsubishi Tanabe
Moberg Derma
Mochida Pharmaceutical Co.
Morria
Mount Sinai School of Medicine
Mycenax Biotech
Mylan
NanoBio Corporation
Nanodermatology Society
National Cancer Institute (US)
National Health Service (NHS, UK)
National Institute for Health and Clinical Excellence (NICE, UK)
National Institute of Allergy and Infectious Diseases (NIAID, US)
Nestlé
Nitric Biotherapeutics
Northwestern University
Novartis
Nycomed
Onset Therapeutics
Oplon-Pure Science
Orient Pharma
Ortho Dermatologics
OSI Pharmaceuticals
Par Pharmaceuticals
Paratek
Perrigo
Pfizer
PhotoCure
Pliva
Provectus Pharmaceuticals
QuatRx Pharmaceuticals
Rabin Medical Centre
Ranbaxy
Regeneron Pharmaceuticals
Roche
Roxane Laboratories
Sandoz (part of Novartis)
Sanofi
Schering-Plough
Senetek
Serentis
Sheba Medical Centre
Shinogi
SkinMedica
Sol-Gel
Star Pharma
Stiefel
Summit
Takeda Pharmaceuticals
Taro Pharmaceutical Industries
Teva Pharmaceutical Industries
Tolmar
Tufts Medical Center
University of British Columbia
University of California
Valeant Pharmaceuticals
Vascular Biogenic
Vicept
Visonac
Warner Chilcott
Watson Laboratories
Welichem Biotech
Zalicus
Zurita Laboratorio Farmaceutico